Elan Pharmaceuticals
E133121
analgesic drug
biotechnology company
drug delivery business unit
monoclonal antibody
monoclonal antibody drug
pharmaceutical company
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Elan Drug Technologies | 1 |
| Elan Pharmaceuticals canonical | 1 |
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
analgesic drug
ⓘ
biotechnology company ⓘ drug delivery business unit ⓘ monoclonal antibody ⓘ monoclonal antibody drug ⓘ pharmaceutical company ⓘ pharmaceutical company ⓘ |
| acquiredBy | Perrigo ⓘ |
| acquisitionCompletedIn | 2013 ⓘ |
| coDevelopedWith |
Biogen
ⓘ
surface form:
Biogen Idec
|
| collaboratedWith |
Johnson & Johnson
ⓘ
Wyeth ⓘ |
| country | Ireland ⓘ |
| defunctSince | 2013 ⓘ |
| developed |
Tysabri
ⓘ
bapineuzumab ⓘ |
| developedFor | Alzheimer's disease ⓘ |
| experienced | Tysabri market withdrawal in 2005 ⓘ |
| focusesOn |
autoimmune diseases
ⓘ
neurological diseases ⓘ |
| foundedIn | 1969 ⓘ |
| founder | Donal E. R. Geaney ⓘ |
| hadControversy | Tysabri safety concerns ⓘ |
| hadEmployeeCountApprox | 1700 ⓘ |
| hadProduct | Prialt ⓘ |
| hadSubsidiary |
Elan Pharmaceuticals
self-linksurface differs
ⓘ
surface form:
Elan Drug Technologies
|
| headquartersLocation | Dublin ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor | drug delivery technologies ⓘ |
| laterResumed | Tysabri marketing ⓘ |
| listedOn | Irish Stock Exchange ⓘ |
| operatedIn |
Europe
ⓘ
Ireland ⓘ United States of America ⓘ
surface form:
United States
|
| researchArea |
Alzheimer's disease
ⓘ
Parkinson's disease ⓘ autoimmune disorders ⓘ multiple sclerosis ⓘ |
| specializesIn |
central nervous system disorders
ⓘ
neurodegenerative diseases ⓘ |
| status | defunct ⓘ |
| stockExchange | New York Stock Exchange ⓘ |
| tickerSymbol | ELN ⓘ |
| tradedAs | NYSE:ELN ⓘ |
| treats |
Crohn's disease
ⓘ
multiple sclerosis ⓘ |
| usedFor | severe chronic pain ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Elan Drug Technologies